ABSTRACT
Abstract Background: Topical corticosteroids (TCS) are the mainstay of treatment in atopic dermatitis (AD) flares. The fears and worries concerning TCS are known as corticophobia. Corticophobia is common in patients with AD and can lead to suboptimal TCS application and treatment failure. Health literacy (HL) may influence corticophobia. TOPICOP© and HLS-EU-PT questionnaires have been developed to evaluate corticophobia and HL, respectively. Objective: Evaluate the relationship between corticophobia and the degree of HL in patients with AD. Methods: Prospective cross-sectional study with AD patients followed at a Dermatology Department, between September 2019 and February 2020. Patients, or their parents (if patients had ≤ 15 years), were invited to answer TOPICOP© questionnaire, HLS-EU-PT questionnaire, and a disease characterization and demographic questionnaire. Results: We included 61 patients (57.4% females, mean age 20 ± 13.8 years, mean disease duration of 12.5 ± 11.4 years). TOPICOP© mean score was 44.8 ± 20.0 (8.3 to 88.9) and HLS-EU-PT mean score was 30.5 ± 8.5 (1.1 to 47.9). TOPICOP© score was negatively correlated with HLS-EU-PT score (p = 0.002, r = -0.382, r2 = 0.146). There was no statistical difference between TOPICOP© score and disease characteristics (disease severity, family history of AD or personal history of other atopic diseases). Study limitations: Small and heterogenous cohort composed of patients and patients' parents. Conclusions: The degree of corticophobia is similar to the values reported in other studies. HL had an inverse correlation with corticophobia. Lower HL was shown to be a predictor of higher corticophobia. The promotion of health literacy is essential for the correct use of TCS and good control of AD.
ABSTRACT
BACKGROUND: Topical corticosteroids (TCS) are the mainstay of treatment in atopic dermatitis (AD) flares. The fears and worries concerning TCS are known as corticophobia. Corticophobia is common in patients with AD and can lead to suboptimal TCS application and treatment failure. Health literacy (HL) may influence corticophobia. TOPICOP© and HLS-EU-PT questionnaires have been developed to evaluate corticophobia and HL, respectively. OBJECTIVE: Evaluate the relationship between corticophobia and the degree of HL in patients with AD. METHODS: Prospective cross-sectional study with AD patients followed at a Dermatology Department, between September 2019 and February 2020. Patients, or their parents (if patients had ≤ 15 years), were invited to answer TOPICOP© questionnaire, HLS-EU-PT questionnaire, and a disease characterization and demographic questionnaire. RESULTS: We included 61 patients (57.4% females, mean age 20 ± 13.8 years, mean disease duration of 12.5 ± 11.4 years). TOPICOP© mean score was 44.8 ± 20.0 (8.3 to 88.9) and HLS-EU-PT mean score was 30.5 ± 8.5 (1.1 to 47.9). TOPICOP© score was negatively correlated with HLS-EU-PT score (p = 0.002, r = -0.382, r2 = 0.146). There was no statistical difference between TOPICOP© score and disease characteristics (disease severity, family history of AD or personal history of other atopic diseases). STUDY LIMITATIONS: Small and heterogenous cohort composed of patients and patients' parents. CONCLUSION: The degree of corticophobia is similar to the values reported in other studies. HL had an inverse correlation with corticophobia. Lower HL was shown to be a predictor of higher corticophobia. The promotion of health literacy is essential for the correct use of TCS and good control of AD.
Subject(s)
Dermatitis, Atopic , Dermatologic Agents , Health Literacy , Phobic Disorders , Adolescent , Adult , Child , Cross-Sectional Studies , Dermatitis, Atopic/drug therapy , Female , Glucocorticoids , Humans , Male , Prospective Studies , Surveys and Questionnaires , Young AdultABSTRACT
Alternaria species belong to a group of opportunistic fungi that causes skin infection mainly in immunosuppressed patients. The authors describe two clinically distinct cases of cutaneous alternariosis caused by Alternaria infectoria in patients under prolonged corticosteroid treatment. Additionally, a brief review of published cases in portuguese patients is conducted.
As espécies Alternaria pertencem a um grupo de fungos oportunistas que causam infeções cutâneas, nomeadamente, em doentes imunocomprometidos. Os autores descrevem dois casos clínicos distintos de alternariose cutânea causada por Alternaria infectoria em doentes sob corticoterapia prolongada. Adicionalmente, é também feita uma breve revisão dos casos publicados em doentes portugueses.
Subject(s)
Alternariosis , Dermatomycoses , Phaeohyphomycosis , Alternaria , Alternariosis/diagnosis , Alternariosis/drug therapy , Dermatomycoses/diagnosis , Dermatomycoses/drug therapy , Humans , Immunocompromised Host , Phaeohyphomycosis/diagnosis , Phaeohyphomycosis/drug therapyABSTRACT
Solar urticaria is a rare form of physical urticaria mediated by immunoglobulin E. The lesions appear immediately after the sun exposure, interfering with the patient's normal daily life. Omalizumab, a monoclonal anti-IgE antibody, has been recently approved for the treatment of chronic spontaneous urticaria, and the latest reports support its role also in the treatment of solar urticaria. Hereby, we report a case of solar urticaria refractory to conventional treatment strategies, with an excellent response to treatment with omalizumab and phototesting normalization.
Subject(s)
Anti-Allergic Agents/therapeutic use , Omalizumab/therapeutic use , Sunlight/adverse effects , Urticaria/drug therapy , Humans , Male , Middle Aged , Photosensitivity Disorders/diagnosis , Photosensitivity Disorders/drug therapy , Photosensitivity Disorders/etiology , Urticaria/diagnosis , Urticaria/etiologyABSTRACT
Abstract: Solar urticaria is a rare form of physical urticaria mediated by immunoglobulin E. The lesions appear immediately after the sun exposure, interfering with the patient's normal daily life. Omalizumab, a monoclonal anti-IgE antibody, has been recently approved for the treatment of chronic spontaneous urticaria, and the latest reports support its role also in the treatment of solar urticaria. Hereby, we report a case of solar urticaria refractory to conventional treatment strategies, with an excellent response to treatment with omalizumab and phototesting normalization.
Subject(s)
Humans , Male , Middle Aged , Sunlight/adverse effects , Urticaria/drug therapy , Anti-Allergic Agents/therapeutic use , Omalizumab/therapeutic use , Photosensitivity Disorders/diagnosis , Photosensitivity Disorders/etiology , Photosensitivity Disorders/drug therapy , Urticaria/diagnosis , Urticaria/etiologyABSTRACT
Reticulohistiocytomas represent a group of benign histiocytic dermal proliferations, which occur either sporadically as solitary cutaneous nodules or, when multiple, in association with systemic disease. Due to its nonspecific clinical presentation, reticulohistiocytoma may mimic other benign or malignant skin neoplasms; therefore, in most cases, a biopsy is needed in order to establish the correct diagnosis. The histology is typically characterized by the presence of large histiocytes with abundant eosinophilic cytoplasm with immunohistochemical profile positive for CD68, CD163, and vimentin. The authors report the case of a patient with solitary reticulohistiocytoma with illustrative clinical, dermoscopic, and histologic features.
Subject(s)
Foot Dermatoses/diagnosis , Histiocytosis, Non-Langerhans-Cell/diagnosis , Toes , Dermoscopy , Diagnosis, Differential , Female , Foot Dermatoses/pathology , Histiocytosis, Non-Langerhans-Cell/pathology , Humans , Immunohistochemistry , Middle Aged , Toes/pathologyABSTRACT
Abstract: Reticulohistiocytomas represent a group of benign histiocytic dermal proliferations, which occur either sporadically as solitary cutaneous nodules or, when multiple, in association with systemic disease. Due to its nonspecific clinical presentation, reticulohistiocytoma may mimic other benign or malignant skin neoplasms; therefore, in most cases, a biopsy is needed in order to establish the correct diagnosis. The histology is typically characterized by the presence of large histiocytes with abundant eosinophilic cytoplasm with immunohistochemical profile positive for CD68, CD163, and vimentin. The authors report the case of a patient with solitary reticulohistiocytoma with illustrative clinical, dermoscopic, and histologic features.
Subject(s)
Female , Middle Aged , Toes/pathology , Histiocytosis, Non-Langerhans-Cell/diagnosis , Foot Dermatoses/diagnosis , Immunohistochemistry , Histiocytosis, Non-Langerhans-Cell/pathology , Dermoscopy , Diagnosis, Differential , Foot Dermatoses/pathologySubject(s)
Exanthema/diagnosis , Child , Child, Preschool , Diagnosis, Differential , Female , HumansSubject(s)
Eosinophilia/pathology , Erythema/pathology , Prednisolone/therapeutic use , Skin Diseases, Genetic/pathology , Administration, Oral , Aged , Biopsy, Needle , Blood Chemical Analysis , Eosinophilia/diagnosis , Eosinophilia/drug therapy , Erythema/diagnosis , Erythema/drug therapy , Female , Follow-Up Studies , Humans , Immunohistochemistry , Skin Diseases, Genetic/diagnosis , Skin Diseases, Genetic/drug therapy , Thoracic WallSubject(s)
HIV Infections/diagnosis , HIV-1 , Penile Diseases/virology , Skin Ulcer/virology , Acyclovir/analogs & derivatives , Acyclovir/therapeutic use , Anti-HIV Agents/therapeutic use , Antiviral Agents/therapeutic use , Chronic Disease , HIV Infections/drug therapy , Humans , Male , Penile Diseases/drug therapy , Valacyclovir , Valine/analogs & derivatives , Valine/therapeutic use , Young AdultSubject(s)
Hand Injuries , Sporotrichosis/etiology , Wounds, Penetrating/complications , Aged , Antifungal Agents/administration & dosage , Dose-Response Relationship, Drug , Humans , Itraconazole/administration & dosage , Male , Rosa , Sporotrichosis/drug therapy , Sporotrichosis/pathology , Wounds, Penetrating/drug therapyABSTRACT
Cowden syndrome is a rare autosomal dominant condition characterised by mucocutaneous hamartomas and, most importantly, predisposition to various extracutaneous benign and malignant tumours. This disorder is associated with a germline mutation in the phosphatase and tensin homologue gene, a tumour suppressor gene, located on 10q23 chromosome. The expressivity of this genodermatosis is highly variable, therefore many of the cases remain undiagnosed. Skin and mucous findings are very common in Cowden syndrome and may represent the initial clinical manifestation leading to the diagnosis. The authors describe a case of a 58-year-old man with multiple cutaneous sclerotic fibromas associated with a previously unrecognised Cowden syndrome.
